Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation: Metabolic drug interactions
References (33)
- et al.
Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer
Cancer Treat Rev
(1980) - et al.
Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate cytochrome P-450 reduced from rabbit liver microsomes
J Biol Chem
(1974) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding
Anal Biochem
(1976)- et al.
Cytochrome p-450 isozyme LM3b from rabbit liver microsomes
J Biol Chem
(1983) - et al.
Triacetyloleandomycin as inducer of cytochrome P-4503C from rabbit liver microsomes
Biochem Pharmacol
(1985) - et al.
Expression of five forms of microsomal cytochrome P-450 in primary culture of rabbit hepatocytes treated with various classes of inducers
Biochem Pharmacol
(1987) - et al.
Variability in nifedipine pharmacokinetics and dynamics. A new oxidation polymorphism in man
Biochem Pharmacol
(1984) Critical review of pharmacology, pharmacokinetics of vincristine, vindesine, vinblastine
Beitr Onkol
(1981)- et al.
The vinca alkaloids: a new class of oncolytic agents
Cancer Res
(1963) - et al.
Clinical pharmacokinetics of navelbine after oral administration in cancer patients
Cancer Chemother Pharmacol
(1991)
Interpatient and intrapatient variability in vinblastine pharmacokinetics
Clin Pharmacol Ther
(1987)
Pharmacokinetics of vincristine infusion
Cancer Treat Rep
(1981)
Pharmacokinetics of vindesine bolus and infusion
Cancer Chemother Pharmacol
(1984)
Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans
Cancer Res
(1985)
Clinical pharmacokinetics of vinblastine by continuous intravenous infusion
Cancer Res
(1983)
Clinical pharmacokinetics of vindesine: repeated treatments by intravenous bolus injections
Eur J Cancer Clin Oncol
(1984)
Cited by (0)
Copyright © 1993 Published by Elsevier Inc.